Moreover, IL-2 might contribute to the pathogenesis of SCLS [1], based on the fact that IL-2 therapy can develop a leakage syndrome undistinguishable from SCLS [13]. The gene discussed is IL2; the disease is Systemic capillary leak syndrome.